Yes. As of July 2026, Agilent Technologies, Inc. (A) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 8.47% / 30% · (Cash+Inv) / Mkt Cap (36m) 4.05% / 30% · Interest income / Revenue 0.80% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 8.47% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 3.77% / 33% · Receivables / Mkt Cap (36m) 3.17% / 49% · Interest income / Revenue 0.80% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 8.47% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 3.77% / 33.33% · Receivables / Mkt Cap (24m) 3.17% / 33.33% · Interest income / Revenue 0.80% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 26.7% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 13.5% / 33.33% · Receivables / Avg Assets (4Q) 11.4% / 33.33% · Interest income / Revenue 0.80% / 5% | Pass |
| FTSE | Debt / Total Assets 28.3% / 33.33% · (Cash+ST Inv) / Total Assets 12.6% / 33.33% · (Cash+Recv) / Total Assets 23.2% / 33.33% · Interest income / Revenue 0.80% / 5% | Pass |
Yes. As of July 2026, Agilent Technologies, Inc. (A) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Agilent Technologies, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.80% of each dividend: Agilent Technologies, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated July 31, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.
Agilent Technologies, Inc. (NYSE: A) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $48.5B. The Maz Rating grades it against the other companies in its sector.
Agilent Technologies, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $171.99, Agilent Technologies, Inc. trades at 34.0x trailing earnings, 6.6x sales and 6.6x book value, with an EV/EBITDA of 25.0. Over the last twelve months it generated about $7.3B of revenue and $1.4B of net income. It runs a gross margin of 53.7%, an operating margin of 22.2% and a net margin of 19.5%. It shows return on equity of 20.5%, return on invested capital of 11.9% and a free cash flow yield of 2.6%. On the balance sheet: a debt-to-equity ratio of 0.54 and a current ratio of 2.05. Over the past 52 weeks the share price ranged from $108.35 to $182.99, with a beta of 1.24.
Agilent Technologies, Inc. pays a dividend yielding 0.59%, with 20% of earnings paid out. Its Maz Dividend Score is 3.23 out of 5, ranked against the other dividend payers in its sector (Safety 3.83, Growth 3.23, Yield 1.63, Consistency 3.00).
41 Wall Street analyst ratings cover the stock: 1 Strong Buy, 32 Buy, 7 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.